Among those with Lynch syndrome due to a PV in a MMR gene (MLH1, MSH2, MSH6, and PMS2), 61.0% (25/41) were subsequently diagnosed with endometrial cancer, 24.4% (10/41) with colorectal cancer, and 3 patients with both. This evidence concerns the gene MSH2 and Lynch syndrome.